Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women

Cancer Research

Volumn 65, Issue 17, 2005, Pages 8028-8033

  Canter, Jeffrey A ^a,d   Kallianpur, Asha R ^b   Parl, Fritz F ^a   Millikan, Robert C ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c IL   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

ADULT; AFRICAN AMERICAN; ARTICLE; BREAST CANCER; CASE CONTROL STUDY; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BREAST NEOPLASMS; DNA, MITOCHONDRIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; OXIDATIVE STRESS; PILOT PROJECTS; POLYMORPHISM, GENETIC;

EID: 24744442376     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-1428     Document Type: Article

References (62)

1. Wallace DC. Mitochondrial diseases in man and mouse. Science 1999;283:1482-8.
2. Wallace DC. Mitochondrial DNA in aging and disease. Sci Am 1997;227:40-7.
3. Papa S. Mitochondrial oxidative phosphorylation changes in the life span. Molecular aspects and physiopathological implications. Biochim Biophys Acta 1996;1276:87-105.
4. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med 2003;348:2656-68.
5. Richter C, Park JW, Ames BN. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci U S A 1988;85:6465-7.
6. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003;552:335-44.
7. Halliwell B, Gutteridge JMC, editors. Free radicals in biology and medicine. 3rd ed. Oxford: Oxford University Press; 1999.
8. Kang D. Hamasaki N. Mitochondrial oxidative stress and mitochondrial DNA. Clin Chem Lab Med 2003;41:1281-8.
9. Scheffler IE. Mitochondria. New York: Wiley-Liss; 1999.
10. Feig DI, Reid TM, Loeb LA. Reactive oxygen species in tumorigenesis. Cancer Res 1994;54:1890-4s.
11. de Zwart LL, Meerman JH, Commandeur JN, Vermeulen NP. Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 1999;26:202-6.
12. Penta JS, Johnson FM, Wachsman JT, Copeland WC. Mitochondrial DNA in human malignancy. Mutat Res 2001;488:119-33.
13. Cavelli LR, Liang BC. Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved? Mutat Res 1998;398:19-26.
14. Petros JA, Baumann AK, Ruiz-Pesini E, et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A 2005;102:719-24.
15. Yeager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996;36:203-32.
16. Yoshie Y, Ohshima H. Synergistic induction of DNA strand breakage by catechol-estrogen and nitric oxide: implications for hormonal carcinogenesis. Free Radic Biol Med 1998;24:341-8.
17. Roy D, Liehr JG. Changes in activities of free radical detoxifying enzymes in kidneys of male Syrian hamsters treated with estradiol. Cancer Res 1989;49:1475-80.
18. Liehr JG, Jones JS. Role of iron in estrogen-induced cancer. Curr Med Chem 2001;8:839-49.
19. van der Walt JM, Nicodemus KK, Martin ER, et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 2003;72:804-11.
20. van der Walt JM, Dementieva YA, Martin ER, et al. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 2004;365:28-32.
21. Shoffner JM, Brown MD, Torroni A, et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 1993;17:171-84.
22. Giacchetti M, Monticelli I, De Biase L, et al. Mitochondrial DNA haplogroups ingluence the Friedreich's phenotype. J Med Genet 2004;41:293-5.
23. Mancuso M, Francesca LC, Rocchi A, et al. Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? Neurosci Lett 2004;371:158-62.
24. Tanaka M, Gong JS, Zhang J, Yoneda M, Yagi K. Mitochondrial genotype is associated with longevity. Lancet 1998;351:185-6.
25. Ivanova R, Leapage V, Charron D, Schachter F. Mitochondrial genotype associated with French Caucasian centenarians. Gerontology 1998;44:349.
26. Ross OA, McCormack R, Curran MD, et al. Mitochondrial DNA polymorphism: its role in longevity of the Irish population. Exp Gerontol 2001;36:1161-78.
27. Parker WD Jr, Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 1989;26:719-23.
28. Schapira AH, Copper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989;1:1269.
29. Schapria AH, Cooper JM, Dexter D, et al. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990;54:823-7.
30. Swerdlow RH, Parks JK, Miller SW, et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 1996;40:663-71.
31. Cassarino DS, Fall CP, Swerdlow RH, et al. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim Biophys Acta 1997;1362:77-86.
32. Orth M, Schapira AH. Mitochondrial involvement in Parkinson's disease. Neurochem Int 2002;40:533-41.
33. Torroni A, Wallace DC. Mitochondrial DNA variation in human populations and implications for detection of mitochondrial DNA mutations of pathological significance. J Bioenerg Biomembr 1994;36:261-71.
34. Bailey LR, Roodi N, Dupont WD, Pari FF. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 1998;58:5038-41.
35. Roodi N, Dupont WD, Moore JH, Pari FF. Association of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer risk. Cancer Res 2004;64:1233-6.
36. Kallianpur AR, Hall LD, Yadav M, et al. Increased prevalence of the HFE C282Y hemochromatosis allele in women with breast cancer. Cancer Epidemiol Biomarkers Prev 2004;13:205-12.
37. Newman B, Moorman PG, Millikan R, et al. The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 1995;35:51-60.
38. Aldrich TE, Vann D, Moorman PG, Newman B. Rapid reporting of cancer incidence in a population-based study of breast cancer: one constructive use of a central cancer registry. Breast Cancer Res Treat 1995;35:61-4.
39. Millikan R, Eaton A, Worley K, et al. HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites. Breast Cancer Res Treat 2003;79:355-64.
40. Weinberg CR, Sandler DP. Randomized recruitment in case-control studies. Am J Epidemiol 1991;134:421-32.
41. Millikan RC, Pittman GS, Newman B, et al. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:371-8.
42. Furberg H, Millikan R, Dressler L, Newman B, Geradts J. Tumor characteristics in African American and white women. Breast Cancer Res Treat 2001;68:33-43.
43. Dupont WD, Plummer WD. Power and Sample Size Calculations: A Review and Computer Program. Controlled Clinical Trials 1990;11:116-28.
44. Smeitink J, van den Heuvel L. Human mitochondrial complex 1 in health and disease. Am J Hum Genet 1999;4:1505-10.
45. Robinson BH. Human Complex 1 deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. Biochim Biophys Acta 1998;1364:271-86.
46. Simon DK, Mayeux R, Marder K, Kowall NW, Beal MF, Johns DR. Mitochondrial DNA mutations in complex 1 and tRNA genes in Parkinson disease. Neurology 2000;54:703-9.
47. Muthane U, Jain S, Gururaj G. Hunting genes in Parkinson's disease from the roots. Med Hypotheses 2001;57:51-5.
48. Ries LAG, Eisner MP, Kosary CL, et al, editors. SEER cancer statistics review, 1975-2000. Bethesda (MD): National Cancer Institute; 2003.
49. Millikan R, Player J, de Cotret AR. et al. Manganese superoxide dismutase (MnSOD) Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites. Breast Cancer Res 2004;6:R264-74.
50. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003;361:567-71.
51. Hall IJ, Moorman PG, Millikan RC, Newman B. Comparative analysis of breast cancer risk factors among African-American women and white women. Am J Epidemiol 2005;161:40-51.
52. Chen G, Heilbrun LK, Venkatramanamoorhty R, et al. Effects of low-fat and or high-fruit-and-vegetable diets on plasma levels of 8-isoprostane-F2α in the Nutrition and Breast Study. Nutr Cancer 2004;50:155-60.
53. Garcia-Ruiz C, Colell A, Mari M, Morales A, Fernandez-Checa JC. Direct effects of ceramide on the mitochondrial electron transport chain lead to generation of reactive oxygen species. J Biol Chem 1997;272:11369-77.
54. Wallace DC. Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci U S A 1994;91:8739-46.
55. Mishmar D, Ruiz-Pesini E, Golik P, et al. Natural selection shaped regional mtDNA variation in humans. Proc Natl Acad Sci U S A 2003;100:171-6.
56. Chen YS, Torroni A, Excoffier L, Santachiara-Benerecetti AS, Wallace DC. Analysis of mtDNA variation in African populations reveals the most ancient of all human continent-specific haplogroups. Am J Hum Genet 1995;57:133-49.
57. Wallace DC, Brown MD, Lott MT. Mitochondrial DNA variation in human evolution and disease. Gene 1999;238:211-30.
58. Autere J, Moilanen JS, Finnila S, et al. Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia. Hum Genet 2004;115:29-35.
59. Niemi AK, Hervonen A, Hurme M, Karhunen PJ, Jylha M, Majamaa K. Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum Genet 2003;112:29-33.
60. Niemi AK, Moilanen JS, Tanaka M, et al. A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects. Eur J Hum Genet 2005;13:166-70.
61. Thompson D, Easton D. The genetic epidemiology of breast cancer genes. J Mam Gland Biol Neopl 2004;9:221-36.
62. Hopper JL. Genetic epidemiology of female breast cancer. Semin Cancer Biol 2001;11:367-74.